Antenatal Corticosteroid Therapy for Fetal Maturation

Obstetrics and Gynecology

Volumn 130, Issue 2, 2017, Pages E102-E109

  El Sayed, Yasser Y ^a   Borders, Ann E B ^a   Gyamfi Bannerman, Cynthia ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CORTICOSTEROID;

ARTICLE; CLINICAL OUTCOME; CORTICOSTEROID THERAPY; FEMALE; FETAL VIABILITY; FETUS MATURITY; GESTATIONAL AGE; HUMAN; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; DRUG ADMINISTRATION; OBSTETRICS; PRACTICE GUIDELINE; PREGNANCY; STANDARDS;

ADRENAL CORTEX HORMONES; BETAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; FETAL ORGAN MATURITY; HUMANS; OBSTETRICS; PREGNANCY; PRENATAL CARE;

EID: 85027497321     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000002237     Document Type: Article

References (55)

1. Periviable birth. Obstetric Care Consensus No. 4. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;127:e157–69. [PubMed] [Obstetrics & Gynecology] ^
2. Carlo WA, McDonald SA, Fanaroff AA, Vohr BR, Stoll BJ, Ehrenkranz RA, et al. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks’ gestation. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. JAMA 2011;306:2348–58. [PubMed] [Full Text] ^
3. Mori R, Kusuda S, Fujimura M. Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation. Neonatal Research Network Japan. J Pediatr 2011;159:110–114.e1. [PubMed] [Full Text] ^
4. Chawla S, Natarajan G, Rane S, Thomas R, Cortez J, Lua J. Outcomes of extremely low birth weight infants with varying doses and intervals of antenatal steroid exposure. J Perinat Med 2010;38:419–23. [PubMed] ^
5. Chawla S, Bapat R, Pappas A, Bara R, Zidan M, Natarajan G. Neurodevelopmental outcome of extremely premature infants exposed to incomplete, no or complete antenatal steroids. J Matern Fetal Neonatal Med 2013;26:1542–7. [PubMed] [Full Text]^
6. Premature rupture of membranes. Practice Bulletin No. 172. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e165–77. [PubMed] [Obstetrics & Gynecology] ^
7. Lee SE, Park JS, Norwitz ER, Kim KW, Park HS, Jun JK. Measurement of placental alpha-microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes. Obstet Gynecol 2007;109:634–40. [PubMed] Obstetrics & Gynecology]^
8. Cousins LM, Smok DP, Lovett SM, Poeltler DM. AmniSure placental alpha microglobulin-1 rapid immunoassay versus standard diagnostic methods for detection of rupture of membranes. Am J Perinatol 2005;22:317–20. [PubMed] [Full Text]^
9. Lee SM, Lee J, Seong HS, Lee SE, Park JS, Romero R, et al. The clinical significance of a positive Amnisure test in women with term labor with intact membranes. J Matern Fetal Neonatal Med 2009;22:305–10. [PubMed] [Full Text]^
10. Lee SM, Romero R, Park JW, Kim SM, Park CW, Korzeniewski SJ, et al. The clinical significance of a positive Amnisure test in women with preterm labor and intact membranes. J Matern Fetal Neonatal Med 2012;25:1690–8. [PubMed] [Full Text] ^
11. Management of preterm labor. Practice Bulletin No. 171. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e155–64. [PubMed] [Obstetrics & Gynecology] ^
12. Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD004454. DOI: 10.1002/14651858.CD004454. pub2. [PubMed] [Full Text]^
13. Antenatal corticosteroids revisited: repeat courses. NIH Consens Statement 2000;17:1–18. [PubMed] ^
14. Fanaroff AA, Hack M. Periventricular leukomalacia—prospects for prevention. N Engl J Med 1999;341:1229–31. [PubMed] Full Text]^
15. Brownfoot FC, Gagliardi DI, Bain E, Middleton P, Crowther CA. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD006764. DOI: 10.1002/14651858.CD006764. pub3. [PubMed] [Full Text]^
16. Lee BH, Stoll BJ, McDonald SA, Higgins RD. Neurodevelopmental outcomes of extremely low birth weight infants exposed prenatally to dexamethasone versus betamethasone. National Institute of Child Health and Human Development Neonatal Research Network. Pediatrics 2008;121:289–96. [PubMed] [Full Text]^
17. Gonzales LW, Ballard PL, Ertsey R, Williams MC. Glucocorticoids and thyroid hormones stimulate biochemical and morphological differentiation of human fetal lung in organ culture. J Clin Endocrinol Metab 1986;62:678–91. [PubMed] ^
18. Abbasi S, Oxford C, Gerdes J, Sehdev H, Ludmir J. Antenatal corticosteroids prior to 24 weeks’ gestation and neonatal outcome of extremely low birth weight infants [published erratum appears in Am J Perinatol 2011;28: 87–8]. Am J Perinatol 2010;27:61–6. [PubMed] [Full Text] ^
19. Vidaeff AC, Ramin SM. Antenatal corticosteroids after preterm premature rupture of membranes. Clin Obstet Gynecol 2011;54:337–43. [PubMed] ^
20. Harding JE, Pang J, Knight DB, Liggins GC. Do antenatal corticosteroids help in the setting of preterm rupture of membranes? Am J Obstet Gynecol 2001;184:131–9. [PubMed] [Full Text] ^
21. Multifetal gestations: twin, triplet, and higher-order multifetal pregnancies. Practice Bulletin No. 169. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e131–46 . [PubMed] [Obstetrics & Gynecology] ^
22. Melamed N, Shah J, Yoon EW, Pelausa E, Lee S, Shah PS, et al. The role of antenatal corticosteroids in twin pregnancies complicated by preterm birth. Canadian Neonatal Network Investigators. Am J Obstet Gynecol 2016; DOI: 10.1016/j.ajog.2016.05.037. [PubMed] [Full Text] ^
23. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement 1994;12:1–24. [PubMed] ^
24. Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita AT, Reddy UM, Saade GR, et al. Antenatal betamethasone for women at risk for late preterm delivery. NICHD Maternal-Fetal Medicine Units Network. N Engl J Med 2016;374:1311–20. [PubMed] [Full Text] ^
25. Harris DL, Weston PJ, Harding JE. Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr 2012;161:787–91. [PubMed] [Full Text] ^
26. Hay WW Jr, Raju TN, Higgins RD, Kalhan SC, Devaskar SU. Knowledge gaps and research needs for understanding and treating neonatal hypoglycemia: workshop report from Eunice Kennedy Shriver National Institute of Child Health and Human Development. J Pediatr 2009;155: 612–7. [PubMed] [Full Text] ^
27. Adamkin DH. Postnatal glucose homeostasis in late-preterm and term infants. Committee on Fetus and Newborn.Pediatrics2011;127:575–9.[PubMed][FullText] ^
28. Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery. Society for Maternal-Fetal Medicine (SMFM) Publications Committee. Am J Obstet Gynecol 2016; DOI: 10.1016/j.ajog.2016.03.013. [PubMed] [Full Text] ^
29. Wapner RJ, Sorokin Y, Thom EA, Johnson F, Dudley DJ, Spong CY, et al. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Am J Obstet Gynecol 2006;195:633–42. [PubMed] [Full Text] ^
30. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 1999;180: 114–21. [PubMed] [Full Text] ^
31. Abbasi S, Hirsch D, Davis J, Tolosa J, Stouffer N, Debbs R, et al. Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome. Am J Obstet Gynecol 2000;182:1243–9. [PubMed] ^
32. Banks BA, Cnaan A, Morgan MA, Parer JT, Merrill JD, Ballard PL, et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol 1999;181:709–17. [PubMed] ^
33. Bloom SL, Sheffield JS, McIntire DD, Leveno KJ. Antenatal dexamethasone and decreased birth weight. Obstet Gynecol 2001;97:485–90. [PubMed] [Obstetrics & Gynecology] ^
34. Thorp JA, Jones PG, Knox E, Clark RH. Does antenatal corticosteroid therapy affect birth weight and head circumference? Obstet Gynecol 2002;99:101–8. [PubMed] [Obstetrics & Gynecology] ^
35. Murphy KE, Hannah ME, Willan AR, Hewson SA, Ohlsson A, Kelly EN, et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. MACS Collaborative Group. Lancet 2008;372: 2143–51. [PubMed] [Full Text] ^
36. Guinn DA, Atkinson MW, Sullivan L, Lee M, MacGregor S, Parilla BV, et al. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial. JAMA 2001;286:1581–7. [PubMed] [Full Text] ^
37. Pratt L, Waschbusch L, Ladd W, Gangnon R, Hendricks SK. Multiple vs. single betamethasone therapy. Neonatal and maternal effects. J Reprod Med 1999;44:257–64. [PubMed] ^
38. Shelton SD, Boggess KA, Murtha AP, Groff AO, Herbert WN. Repeated fetal betamethasone treatment and birth weight and head circumference. Obstet Gynecol 2001; 97:301–4. [PubMed] [Obstetrics & Gynecology] ^
39. Wapner RJ, Sorokin Y, Mele L, Johnson F, Dudley DJ, Spong CY, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. N Engl J Med 2007;357:1190–8. [PubMed] [Full Text] ^
40. Crowther CA, Doyle LW, Haslam RR, Hiller JE, Harding JE, Robinson JS. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. ACTORDS Study Group. N Engl J Med 2007;357:1179–89. [PubMed] ^
41. Asztalos EV, Murphy KE, Hannah ME, Willan AR, Matthews SG, Ohlsson A, et al. Multiple courses of antenatal corticosteroids for preterm birth study: 2-year outcomes. Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study Collaborative Group. Pediatrics 2010;126:e1045–55. [PubMed] [Full Text] ^
42. McKenna DS, Wittber GM, Nagaraja HN, Samuels P. The effects of repeat doses of antenatal corticosteroids on maternal adrenal function. Am J Obstet Gynecol 2000;183: 669–73. [PubMed] [Full Text] ^
43. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515–25. [PubMed] ^
44. Peaceman AM, Bajaj K, Kumar P, Grobman WA. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes. Am J Obstet Gynecol 2005;193:1165–9. [PubMed] [Full Text] ^
45. Garite TJ, Kurtzman J, Maurel K, Clark R. Impact of a ‘rescue course’ of antenatal corticosteroids: a multicenter randomized placebo-controlled trial. Obstetrix Collaborative Research Network [published erratum appears in Am J Obstet Gynecol 2009;201:428]. Am J Obstet Gynecol 2009; 200:248.e1–9. [PubMed] [Full Text] ^
46. Crowther CA, McKinlay CJ, Middleton P, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database of Systematic Reviews 2015, Issue 7. Art. No.: CD003935. DOI: 10.1002/14651858.CD003935. pub4. [PubMed] [Full Text] ^
47. Gyamfi-Bannerman C, Son M. Preterm premature rupture of membranes and the rate of neonatal sepsis after two courses of antenatal corticosteroids. Obstet Gynecol 2014; 124:999–1003. [PubMed] [Obstretrics & Gynecology] ^
48. Sotiriadis A, Tsiami A, Papatheodorou S, Baschat AA, Sarafidis K, Makrydimas G. Neurodevelopmental Outcome After a Single Course of Antenatal Steroids in Children Born Preterm: A Systematic Review and Meta-analysis. Obstet Gynecol 2015;125:1385–96. [PubMed] [Obstretrics & Gynecology] ^
49. Stutchfield PR, Whitaker R, Gliddon AE, Hobson L, Kotecha S, Doull IJ. Behavioural, educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial). Arch Dis Child Fetal Neonatal Ed 2013;98:F195–200. [PubMed] [Full Text] ^
50. Dalziel SR, Lim VK, Lambert A, McCarthy D, Parag V, Rodgers A, et al. Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ 2005;331:665. [PubMed] [Full Text] ^
51. Critical care in pregnancy. Practice Bulletin No. 170. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e147–54. [PubMed] [Obstetrics & Gynecology] ^
52. Kaplan HC, Sherman SN, Cleveland C, Goldenhar LM, Lannon CM, Bailit JL. Reliable implementation of evidence: a qualitative study of antenatal corticosteroid administration in Ohio hospitals. BMJ Qual Saf 2016;25:173–81. [PubMed] [Full Text] ^
53. Wirtschafter DD, Danielsen BH, Main EK, Korst LM, Gregory KD, Wertz A, et al. Promoting antenatal steroid use for fetal maturation: results from the California Perinatal Quality Care Collaborative. J Pediatr 2006;148:606–12. [PubMed] [Full Text] ^
54. Adams TM, Kinzler WL, Chavez MR, Vintzileos AM. The timing of administration of antenatal corticosteroids in women with indicated preterm birth. Am J Obstet Gynecol 2015;212:645.e1–4. [PubMed] [Full Text] ^
55. A statewide project to promote optimal use of antenatal corticosteroids (ANCS). Ohio Perinatal Quality Collaborative [abstract]. Am J Obstet Gynecol 2013;208(suppl):S224. ^